Consensus Bide Pharmatech Co., Ltd.

Equities

688073

CNE100005NV3

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-05-16 EDT			5-day change	1st Jan Change
34.69 ^CNY	+0.84%		-4.54%	-37.50%

04-25	Bide Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-02	Tranche Update on Bide Pharmatech Co., Ltd.'s Equity Buyback Plan announced on December 9, 2023.	CI

Evolution of the average Target Price on Bide Pharmatech Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

281257bde587691c348e5e78dc.OTxP13C1nqn3fRbTEKaTLYbA1kcvfa40RJ03-XCB6CE.d3p9vR7v2cfBC1O5SpTgFfWisgRANZh7HNBjtUn5hmZJXQeFCf-vmrFIWw~4450657ecd54817cecb6411f37fbf41e

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

34.69 CNY

Average target price

41 CNY

Spread / Average Target

+18.19%

High Price Target

41 CNY

Spread / Highest target

+18.19%

Low Price Target

41 CNY

Spread / Lowest Target

+18.19%

Consensus detail

Consensus revision (last 18 months)

Ratings for Bide Pharmatech Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar